BIO-Europe 2026
Fireside chat Regulatory Strategy track
HTA Regulation: Early Insights and Reimbursement Implications
Wed, Nov 11, 2026 · 12:00–12:45 PM CET Regulatory Strategy Stage, Koelnmesse
About this session
Key industry learnings from Joint Clinical Assessment procedures Addressing legal challenges and rare disease economic models Understanding Member States’ early responses to HTA implementation Evaluating whether HTA regulation will streamline market access or introduce new hurdles
